Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

998
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
998
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.9K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.9K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

769
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
769
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

898
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
898

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GWAS Meta-analysis Identifies Novel Associated Loci and Points to Causal Tissues in Central Serous Chorioretinopathy.

medRxiv : the preprint server for health sciences·2026
Same author

Long-Term Follow-Up of PLACE and SPECTRA Trials: Outcomes After Successful and Unsuccessful Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.

American journal of ophthalmology·2026
Same author

From Sound to Stability: Lessons Learned From the CRUSH Study on Hearing Loss Progression and Vestibular Phenotype in Usher Syndrome Type 2A.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2026
Same author

Exploring retinal and choroidal characteristics on multimodal imaging in resolved central serous chorioretinopathy.

Eye (London, England)·2026
Same author

Clinical Features and Outcomes of Bullous Central Serous Chorioretinopathy: A Multicentric Cohort Study.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2025
Same author

Baseline factors that are associated with change in visual acuity in intermediate AMD over two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 2.

Eye (London, England)·2025

Related Experiment Video

Updated: Oct 23, 2025

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.0K

Central Serous Chorioretinopathy - an Overview.

Lieselotte Berger1, Virginie Bühler1, Suzanne Yzer2

  • 1Department of Ophthalmology, Inselspital, Bern University Hospital.

Klinische Monatsblatter Fur Augenheilkunde
|August 20, 2021
PubMed
Summary

Central serous chorioretinopathy (CSCR) involves fluid under the retina, primarily affecting middle-aged men. While many cases resolve spontaneously, chronic forms and complications like choroidal neovascularization may require targeted treatments.

More Related Videos

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
08:22

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Published on: January 12, 2022

4.6K
Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
10:24

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography

Published on: February 19, 2014

13.8K

Related Experiment Videos

Last Updated: Oct 23, 2025

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.0K
Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
08:22

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Published on: January 12, 2022

4.6K
Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
10:24

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography

Published on: February 19, 2014

13.8K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Choroidal Disorders

Background:

  • Central serous chorioretinopathy (CSCR) is a condition causing retinal detachment, predominantly in men aged 30-50.
  • It is classified as acute (less than 4-6 months) or chronic, with multifactorial pathogenesis involving choroidal hyperpermeability.
  • Acute CSCR presents with blurred vision and subretinal fluid (SRF) on OCT, while chronic CSCR leads to visual deterioration and RPE changes.

Purpose of the Study:

  • To review the characteristics, pathogenesis, and management of central serous chorioretinopathy.
  • To discuss diagnostic findings and treatment options for both acute and chronic CSCR.
  • To highlight the role of steroid therapy as a risk factor and the potential complications like choroidal neovascularization (CNV).

Main Methods:

  • Review of literature on central serous chorioretinopathy.
  • Analysis of diagnostic imaging techniques including Optical Coherence Tomography (OCT) and angiography (FA, ICG).
  • Evaluation of treatment outcomes for various therapeutic interventions.

Main Results:

  • Acute CSCR often resolves spontaneously (70-80% of cases) within 4-6 months, but recurrence is common (approx. 50%).
  • Chronic CSCR involves RPE changes and photoreceptor degeneration, with a risk of CNV, especially in older patients.
  • Treatment options include focal laser therapy, photodynamic therapy (PDT) for chronic cases, and anti-VEGF for CNV.

Conclusions:

  • Observation for 4-6 months is recommended for acute CSCR due to favorable spontaneous resolution rates.
  • Steroid use is a significant risk factor for CSCR development or exacerbation.
  • Management strategies vary based on disease duration and presence of complications like CNV, with PDT showing promise in chronic CSCR.